Business
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction)Median time to graft of 11 days, with grafting as early as 5
About this update from Avita Medical, Inc.
Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction) Median time to graft of 11 days, with grafting as early as 5 days Study ongoing with full dataset expected in 2026 Management to host Key Opinion Leader webinar at 4:30 p.m. ET on April 16 during the American Burn Association Annual Meeting VALENCIA, Calif. , April 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical ®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced positive interim results from its Cohealyx-I multi-center study demonstrating a reduction of nearly 20 days in mean time to skin grafting (13.6 days vs 33.2 days benchmark) for patients with full-thickness wounds. The results demonstrated statistical superiority (p
View stock analysis, news, and events for Avita Medical, Inc.